WCH25: Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice

Section cover

Released on

February 15, 2025

WCH25: Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice

This activity is supported by an educational grant from Lilly USA, LLC.